[OncoHost in PR Newswire] OncoHost receives New York StatelLaboratory permit, expanding availability of PROphetNSCLC® precision oncology test
BINYAMINA, Israel and CARY, N.C., Oct. 22, 2025 /PRNewswire/ — OncoHost, a technology company transforming the approach to precision medicine through plasma proteomics and AI, today announced that it has received a laboratory permit from the New York State Department of Health Wadsworth Center. This permit enables the company to offer its PROphetNSCLC® test to physicians and patients across New York State, marking a key milestone in OncoHost’s U.S. expansion. Read more...
Read More